HOPE Adds Robotic TMS System Ahead of SPARC Trial
WILMINGTON, DE — NRx Pharmaceuticals Inc. said its HOPE Therapeutics subsidiary will become the first interventional psychiatry network to deploy Zeta Surgical’s newly FDA-cleared robotic transcranial magnetic stimulation system, expanding …
HOPE Adds Robotic TMS System Ahead of SPARC Trial Read More